Weight-Loss drugs under the microscope: do they really change what you eat?

NCT ID NCT07270497

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how popular weight-loss medications (GLP-1 and GIP/GLP-1 analogs) affect what people eat, their metabolism, and behavior over a year. Researchers will track 100 adults with overweight or obesity to see changes in weight, body composition, and diet quality. The goal is to understand both the benefits and risks, like muscle loss or side effects, to help patients and doctors make better treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLP-1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Klinika Diabetologii i Chorób Wewnętrznych Uniwersyteckiego Centrum Klinicznego Warszawskiego Uniwersytetu Medycznego

    RECRUITING

    Warsaw, Warszawa, 02-097, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.